CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how ... Feb 26
... Feb 14
Digital biomarker startup Koneksa has raised $45 million in their Series C funding round.... Feb 08
Swiss healthcare giant Novartis has agreed to pay $1.5 billion to acquire British biotech company Gyroscope Therapeutics. ... Dec 24
Latest Pharma news update... Oct 12
Latest Pharma News Update... Aug 31
FDA breakthrough therapy for Novartis metastatic prostate cancer drug ... Jun 21
... Mar 25
Novartis receives FDA Breakthrough Therapy designations for investigational STAMP inhibitor asciminib (ABL001) in chronic myeloid leukaemia ... Feb 10
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
... Dec 17
The acquisition will give Novartis full rights to Cadent’s neuroscience portfolio... Dec 17
The data will be further analyzed to determine any potential impact on other studies of ruxolitinib in patients with COVID-19, and will be submitted ... Dec 15
... Dec 09
The digital networking space offers real-time, face-to-face engagement, which maximises chance encounters with other attendees... Nov 12
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids and shuns ... Nov 10
WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD.... Nov 06
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in the first-of-its-kind study... Nov 05
first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia... Oct 31
Novartis and Molecular Partners AG today announced a collaboration to develop two DARPin® therapies designed for potential use against COVID-19... Oct 28
This new partnership represents Dyno’s largest collaboration to date and this will expand the frontier of gene therapies for the central nervous system and ... Oct 15
Five-year open-label extension study shows patients continued to experience a sustained benefit; Aimovig maintained a consistent safety profile ... Oct 03
Lupin launches generic version of Novartis's Tykerb Tablets... Sep 30
Lupin announced today the launch of Lapatinib Tablets, 250 mg, after Lupin’s alliance partner Natco Pharma Ltd received final approval for its ANDA from ... Sep 30
ACTO cements its position as the largest life sciences commercial learning and development platform ... Sep 15
-Advertisements-
Tuesday, April 23, 2024
